Pavmed (NSDQ:PAVM) said today that it expects to reel in $10.4 million in gross proceeds from an oversubscribed rights offering that expired this week.
The New York-based company received subscriptions exceeding the number of rights available under the offering, Pavmed said, adding that it anticipates the offering will close on June 12.
Get the full story at our sister site, Drug Delivery Business News.
The post Pavmed lands $10m from oversubscribed rights offering appeared first on MassDevice.
from MassDevice https://ift.tt/2JE74RF
Cap comentari:
Publica un comentari a l'entrada